Overview

The University of Kansas Cancer Center Breast Cancer Year in Review is a condensed review of new data and advances published throughout the year and presented at key oncology meetings. It gives healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care. This accredited meeting is hosted as an in-person conference only with on-demand access for registered attendees.

Learning Objectives

• Determine best application of new targeted therapies in patients with early stage and metastatic disease
• Discuss the advances in systemic therapy likely to change current practices for treatment of breast cancer
• Know how to utilize genomic tools for systemic therapy decision making and prediction of treatment response.
• Be familiar with germ-line genetic testing options for hereditary breast cancer, including advantages and disadvantages of extended panel testing
• Evaluate local therapy options for operable breast cancer depending on stage, and the use of neoadjuvant therapy
• Identify evidence-based recommendations for decreasing symptoms and improving quantity and/or quality of life in survivors

Accreditation

Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.